Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gi Kim Min"'
Publikováno v:
In Applied Surface Science 15 January 2025 679
Autor:
Kim Jeeyoung, Bang Weon Jeong, Woo Jung, Kim Younghwa, Shin Hee Jung, Kim Junoh, Gi Kim Min, Joo Yung Hyup, Lee Chang-Seok
Publikováno v:
Archives of Biological Sciences, Vol 75, Iss 3, Pp 279-286 (2023)
To protect the body against environmental threats, cosmetics can play important antiinflammatory and anti-aging roles. Many researchers have developed cosmetic ingredients using natural plant extracts or the active compounds of such extracts. In this
Externí odkaz:
https://doaj.org/article/34618f78deb34b388e701c70d87ca0d6
Autor:
Bong Lee, Jong, Zang, Xiaowei, Zgair, Atheer, Qian Ooi, Ting, Foley, David W, Voronin, Gregory, Kagan, Leonid, Soukarieh, Fadi, Gao, Rui, Shao, Hao, Tying Soh, Wan, Hwan Kim, Tae, Gi Kim, Min, Yun, Hwi-yeol, Wilson, Anthony J., Fischer, Peter M., Gershkovich, Pavel
For treatment of chronic cancers, the oral administration route is preferred as it provides numerous advantages over other delivery routes. However, these benefits of oral chemotherapy can be limited due to unfavorable pharmacokinetics. Accordingly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c78b7e8aec545aae7084ad1f644ecce0
https://orca.cardiff.ac.uk/id/eprint/141387/1/EJPB-D-21-00303.pdf
https://orca.cardiff.ac.uk/id/eprint/141387/1/EJPB-D-21-00303.pdf
Autor:
Kwon, Woo‐Keun1 (AUTHOR), Yoo, Chang‐Min2 (AUTHOR), Kim, Jang Hun3 (AUTHOR), Kim, Tae‐Won2 (AUTHOR), Kim, An‐Gi2 (AUTHOR), Hwang, Min‐Ho2 (AUTHOR) cannone86@korea.ac.kr, Choi, Hyuk2 (AUTHOR) hyuk76@korea.ac.kr
Publikováno v:
Bioengineering & Translational Medicine. Nov2023, Vol. 8 Issue 6, p1-13. 13p.
Autor:
Ji, Jung Hwan1,2 (AUTHOR), Bae, Soong June1,2 (AUTHOR), Kim, Seul‐Gi3 (AUTHOR), Kim, Min Hwan3 (AUTHOR), Kim, Gun‐Min3 (AUTHOR), Sohn, Joohyuk3 (AUTHOR), Jeong, Joon1,2 (AUTHOR), Kim, Jee Hung2,4 (AUTHOR) ok8504@yuhs.ac, Ahn, Sung Gwe1,2 (AUTHOR) asg2004@yuhs.ac
Publikováno v:
Cancer Medicine. Jan2023, Vol. 12 Issue 2, p1409-1417. 9p.
Autor:
Kim, Jung Gi, Jang, Min Ji, Park, Hyung Keun, Chin, Kwang-Geun, Lee, Sunghak, Kim, Hyoung Seop
Publikováno v:
Metals & Materials International; Jul2019, Vol. 25 Issue 4, p912-917, 6p
Autor:
Jung Hwan Ji, Soong June Bae, Seul-Gi Kim, Min Hwan Kim, Gun-Min Kim, Joohyuk Sohn, Jee Hung Kim, Sung Gwe Ahn, Joon Jeong
Publikováno v:
Cancer Research. 82:P2-12
Purpose In the patients treated with neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) regimen, grade 3-4 anemia occurs frequently during the treatment course. Anemia develops mainly by cytotoxic drug including carboplatin. By contrast,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a28e2f1c64469789450a13ab9cf16a85
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-13
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-13
Autor:
Seul-Gi Kim, Min Hwan Kim, Sejung Park, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Byeong Woo Park, Seung Il Kim, Jung Hwan Ji, Joon Jeong, Kabsoo Shin, Jieun Lee, Hyung-Don Kim, Kyung Hae Jung, Joohyuk Sohn
Publikováno v:
Cancer Research. 82:P1-17
Background. Endocrine therapy plus CDK 4/6 inhibitors is the foremost treatment for hormone receptor (HR) positive metastatic breast cancers (mBC). Previously, we reported safety profiles of palbociclib use with grade 3 neutropenia in HR-positive mBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52df51edfa0a64665337d6b7fee3fcdf
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-09
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-09
Publikováno v:
Chemical Science; Dec2015, Vol. 6 Issue 12, p6683-6704, 22p
Publikováno v:
Magnetic Resonance in Medicine; Oct1993, Vol. 30 Issue 4, p405-408, 4p